New drug candidate improves Parkinson's treatment in animal models
Researchers at the University of California, San Diego have identified a new drug candidate that shows promise in improving Parkinson's disease treatment in animal models. The study aims to address limitations of current standard treatments like L-dopa.
Why it matters
Advancements in Parkinson's research are critical for improving the quality of life for millions suffering from neurodegenerative conditions.
Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Videos Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Videos Contact Meet the Team Advertise Search Become a Member New drug candidate improves Parkinson's treatment in animal models Download PDF Copy Add News Medical on Google as a preferred source University of California - San Diego Jul 15 2026 Reviewed For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may stiffen. Walking can become slower and balance more uncertain. The most effective treatment remains L-dopa, also called levodopa, a medication that can dramatically improve movement and quality of life. But the relief often comes with a caveat: over time, the drug's benefits can become less reliable, and it can cause erratic, involuntary movements known as dyskinesia.
The article reports on scientific research findings in a straightforward, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in